ACO Dry Eye Short Course (DESC 2026)
Date: 10/08/2026 - 26/10/2026
Venue: Online, 3000, AUSTRALIA
Provider: Australian College of Optometry
Contact: Shazia Tahseen, [E] cpd@aco.org.au, [P] 03 9349 7546
Activity Outline
The ACO Dry Eye Short Course is designed to enhance clinical expertise in the diagnosis and management of dry eye disease. Guided by leading experts, including TFOS DEWS III Vice Chair Professor James S. Wolffsohn, participants will develop practical skills in tear filM assessment, evidence-based treatment, personalised management, and pharmacological care. Through five online modules and interactive case discussion webinars, clinicians will gain the knowledge and confidence to optimise outcomes and grow their dry eye practice.
Learning Objectives
- Explain the anatomical and physiological components
of the ocular surface, eyelids, and tear film, and their
role in maintaining ocular surface health
- Define dry eye disease and describe its classification,
prevalence, and incidence to understand its global
impact
- Evaluate the underlying pathophysiological
mechanisms of dry eye disease, including
inflammation, tear film instability, and meibomian
gland dysfunction, to inform clinical understanding
and treatment planning
- Apply structured clinical history-taking methods to
gather comprehensive information relevant to dry eye
assessment
- Utilise standardized symptom questionnaires to
accurately evaluate and quantify patient-reported dry
eye symptoms
- Perform and interpret ocular surface examination
techniques to identify clinical signs associated with
dry eye disease
- Develop strategies to effectively educate patients
about Dry Eye Disease, including its management,
treatment options, and prognosis, to improve
understanding and engagement in care.
- Compare the indications, benefits, and limitations of
first-line non-pharmacological therapies for Dry Eye
Disease
-
Design evidence based individualized first line
treatment plans
- Describe the role of nutrition in dry eye disease (DED)
pathophysiology
- Summarise the evidence for key nutritional
interventions in DED
- Apply nutrition-based strategies as adjuncts to
conventional DED management
- Counsel patients on realistic, evidence-informed
dietary approaches
- Evaluate the mechanistic pathways targeted by
anti-inflammatory pharmacological therapies
- Appraise the clinical evidence supporting the
indications, efficacy, safety, and limitations of key
anti-inflammatory DED therapies such as
corticosteroids, calcineurin inhibitors, and LFA-1
antagonists
- Design evidence-based treatment strategies that
incorporate topical corticosteroids and
immunomodulators such as cyclosporin for
appropriate clinical scenarios.
- Reframe antibiotics
in dry eye disease from simple anti-infective agents to
mechanism-based biomodulatory therapies
- Highlight the role of inflammation and lid-margin
dysfunction in dry eye disease
- Understand the relationship between dry eye disease
and mental health, to ensure empathetic consultation
and communication
- Understand the quality of life
impacts dry eye has on patients.
- Analyse the mechanisms and risk factors contributing
to post-surgical Dry Eye Disease (e.g., LASIK, cataract
surgery) to inform clinical decision-making and patient
counselling
- Understand when referral to ophthalmology is
warranted, and what tertiary non-surgical
tertiary treatment options might be suitable
Evaluate indications, benefits, and limitations of
surgical interventions for severe dry eye
- Identify clinical indicators for IPL therapy in dry eye
disease, explain its mechanism of action, and outline
standard treatment protocols
- Recognize patient selection criteria for LLLT in dry eye
management, describe its mechanism, and detail
recommended application protocols for optimal
outcomes
- Outline the other clinical applications for light therapy
treatment
- Critically evaluate and integrate evidence-based
techniques for meibomian gland
expression to optimize lipid layer restoration and tear
film stability in patients with dry eye disease
- Consider the indications, contraindications, and
expected outcomes for amniotic membrane
therapy for patients with advanced ocular surface
disease.
- Analyse the pathophysiological links between
autoimmune disorders and Dry Eye Disease to design
comprehensive management strategies that integrate
systemic and ocular considerations
- Develop multidisciplinary care plans for patients with
systemic or autoimmune-related dry eye conditions.
Understand the indications, benefits, and limitations
of therapeutic contact lens options for complex Dry
Eye cases
- Develop communication strategies that set realistic
expectations
-
Foster long-term adherence to dry eye management
plans.Analyse underlying causes of initial treatment failure
- Develop an adaptive approach that integrates:
Patient education
First line treatments
and adjunctive treatments into a revised holistic care
plan.
- Analyze the influence of systemic factors such as sex,
gender, and hormones on the development and
progression of dry eye disease to support
individualized patient care
- Analyze and integrate systemic and topical medication
reviews into a holistic management plan by
identifying and modifying or eliminating offending
agents to optimize ocular health and patient
outcomes
- Formulate a diagnostic profile for patients with
discordant signs and symptoms to guide appropriate
management strategies
- Case based discussion
to apply concepts
learned during the
didatic part of the course
Max CPD hours awarded: 16.75
Session Information
| Name |
|---|
| Overview of Tear Film Anatomy and Physiology Definitions & Epidemiology Pathophysiology |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| No |
| Therapeutic? |
|---|
| No |
| Duration of CPD Session/Module |
|---|
| 1 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 1 |
| Name |
|---|
| Clinical history-taking Symptomology Ocular Examination |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| No |
| Therapeutic? |
|---|
| No |
| Duration of CPD Session/Module |
|---|
| 1 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 1 |
| Name |
|---|
| Patient Education & Communication First-Line NonPharmacological Therapies Personalised Treatment Planning |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| No |
| Therapeutic? |
|---|
| No |
| Duration of CPD Session/Module |
|---|
| 1.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 1.5 |
| Name |
|---|
| Diet modifications |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| No |
| Therapeutic? |
|---|
| No |
| Duration of CPD Session/Module |
|---|
| 0.25 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 0.25 |
| Name |
|---|
| Mechanistic pathways of anti-inflammatory treatments Evidence Behind Dry Eye Anti-Inflammatories |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| No |
| Therapeutic? |
|---|
| Yes |
| Duration of CPD Session/Module |
|---|
| 1 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 1 |
| Name |
|---|
| The role of antibiotics in dry eye. Mental Health |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| No |
| Therapeutic? |
|---|
| Yes |
| Duration of CPD Session/Module |
|---|
| 1 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 1 |
| Name |
|---|
| Post-surgical dry eye disease Non-surgical tertiary treatment options Surgical |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| No |
| Therapeutic? |
|---|
| No |
| Duration of CPD Session/Module |
|---|
| 1 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 1 |
| Name |
|---|
| Intense Pulsed Light Low-Level Light Therapy Other Applications of Light Therapy |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| No |
| Therapeutic? |
|---|
| No |
| Duration of CPD Session/Module |
|---|
| 1 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 1 |
| Name |
|---|
| Meibomian gland expression Amniotic Membranes |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| No |
| Therapeutic? |
|---|
| Yes |
| Duration of CPD Session/Module |
|---|
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 0.5 |
| Name |
|---|
| Dry eye associated with autoimmune conditions Multidisciplinary collaboration Therapeutic contact lens options |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| No |
| Therapeutic? |
|---|
| No |
| Duration of CPD Session/Module |
|---|
| 1 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 1 |
| Name |
|---|
| Tests for Monitoring Treatment Success Communication Strategies for building trust and long-term compliance Troubleshooting and Revising Care Plans |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| No |
| Therapeutic? |
|---|
| No |
| Duration of CPD Session/Module |
|---|
| 1 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 1 |
| Name |
|---|
| Sex, Gender, and Hormones Optimizing Holistic Care Through Medication Review Assessment of patients with only symptoms or ocular surface signs |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| No |
| Therapeutic? |
|---|
| Yes |
| Duration of CPD Session/Module |
|---|
| 1 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 1 |
| Name |
|---|
| Webinar 1 |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| Yes |
| Therapeutic? |
|---|
| No |
| Duration of CPD Session/Module |
|---|
| 1 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 1 |
| Name |
|---|
| Webinar |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| Yes |
| Therapeutic? |
|---|
| No |
| Duration of CPD Session/Module |
|---|
| 1 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 1 |
| Name |
|---|
| Webinar |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| Yes |
| Therapeutic? |
|---|
| No |
| Duration of CPD Session/Module |
|---|
| 1 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 1 |
| Name |
|---|
| Assessment |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| No |
| Therapeutic? |
|---|
| No |
| Duration of CPD Session/Module |
|---|
| 2.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 2.5 |
| Name | Clinical? | Interactive? | Therapeutic? | CPD Hours |
|---|
| Overview of Tear Film Anatomy and Physiology Definitions & Epidemiology Pathophysiology | Yes | No | No | 1 | 1 |
| Clinical history-taking Symptomology Ocular Examination | Yes | No | No | 1 | 1 |
| Patient Education & Communication First-Line NonPharmacological Therapies Personalised Treatment Planning | Yes | No | No | 1.5 | 1.5 |
| Diet modifications | Yes | No | No | 0.25 | 0.25 |
| Mechanistic pathways of anti-inflammatory treatments Evidence Behind Dry Eye Anti-Inflammatories | Yes | No | Yes | 1 | 1 |
| The role of antibiotics in dry eye. Mental Health | Yes | No | Yes | 1 | 1 |
| Post-surgical dry eye disease Non-surgical tertiary treatment options Surgical | Yes | No | No | 1 | 1 |
| Intense Pulsed Light Low-Level Light Therapy Other Applications of Light Therapy | Yes | No | No | 1 | 1 |
| Meibomian gland expression Amniotic Membranes | Yes | No | Yes | 0.5 | 0.5 |
| Dry eye associated with autoimmune conditions Multidisciplinary collaboration Therapeutic contact lens options | Yes | No | No | 1 | 1 |
| Tests for Monitoring Treatment Success Communication Strategies for building trust and long-term compliance Troubleshooting and Revising Care Plans | Yes | No | No | 1 | 1 |
| Sex, Gender, and Hormones Optimizing Holistic Care Through Medication Review Assessment of patients with only symptoms or ocular surface signs | Yes | No | Yes | 1 | 1 |
| Webinar 1 | Yes | Yes | No | 1 | 1 |
| Webinar | Yes | Yes | No | 1 | 1 |
| Webinar | Yes | Yes | No | 1 | 1 |
| Assessment | Yes | No | No | 2.5 | 2.5 |